Bristol Myers Squibb to Host Virtual Investor Event to Discuss ASCO 2021 Highlights Biotech Investing
Enveric Biosciences Announces Definitive Agreement to Acquire MagicMed Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives Pharmaceutical Investing
AbbVie Presents New Late-Breaking Data Analyses Showing Risankizumab Achieves Clinical Remission and Endoscopic Response at Week 12 in Patients with Moderate to Severe Crohn's Disease Biotech Investing
Bristol Myers Squibb Presents New Data at Digestive Disease Week® on Zeposia Highlighting Clinical Benefits and Safety Profile in Patients with Ulcerative Colitis Biotech Investing
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo plus Yervoy for Treatment of Mismatch Repair Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer After Prior Chemotherapy Biotech Investing
Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS in Subjects with Lupus Nephritis Biotech Investing
U.S. Food and Drug Administration Approves Opdivo® as Adjuvant Treatment of Completely Resected Esophageal or Gastroesophageal Junction Cancer in Patients who have Received Neoadjuvant Chemoradiotherapy Biotech Investing
Wellteq Management Webcast on May 25, 2021 Chief Medical Officer - Dr. George Gellert Biotech Investing
